Home - Boston Life Sciences Times

Takeda Appoints Julie Kim as President and CEO

June 24, 2026

Genetix Biotherapeutics, SPIMACO Partner on Gene Therapies in Middle East

June 23, 2026

eGenesis Names Glenn Vraniak CFO and Jennifer Bergheiser Chief Commercial Officer

June 22, 2026

THIS WEEK'S STORIES

Alkermes Reports Positive Phase 2 Results for Alixorexton in Adults With Narcolepsy Type 2

June 18, 2026

Veristat Expands Leadership Team to Support Complex Clinical Development

June 23, 2026

EU Approves Keytruda-Padcev Regimen for Muscle-Invasive Bladder Cancer

June 24, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Most Popular

Ollin Biosciences Raises $330 Million to Advance Eye Disease Drug into Phase 3 Trials

Pathway Labs Launches FDA-Cleared AI Tool for Detecting Six Heart Conditions

LambdaVision, Vast Partner on Space-Based Artificial Retina Manufacturing

Javelin Biotech, Pfizer Study Shows Multi-Tissue Chip Can Predict Human Drug Pharmacokinetics

Recent Comments

EDITOR PICKS

Takeda Appoints Julie Kim as President and CEO

Genetix Biotherapeutics, SPIMACO Partner on Gene Therapies in Middle East

eGenesis Names Glenn Vraniak CFO and Jennifer Bergheiser Chief Commercial Officer

THIS WEEK'S STORIES

Alkermes Reports Positive Phase 2 Results for Alixorexton in Adults With Narcolepsy Type 2

Veristat Expands Leadership Team to Support Complex Clinical Development

EU Approves Keytruda-Padcev Regimen for Muscle-Invasive Bladder Cancer

POPULAR CATEGORY

ABOUT US

FOLLOW US

LATEST ARTICLES

Most Popular

Recent Comments

EDITOR PICKS

THIS WEEK'S STORIES

POPULAR CATEGORY

ABOUT US

FOLLOW US